Influence of follicle-stimulating hormone receptor (FSHR) Ser680Asn polymorphism on ovarian function and in-vitro fertilization outcome: A meta-analysis

被引:64
|
作者
Yao, Yao [1 ,2 ]
Ma, Cai-hong [3 ]
Tang, Hui-lin [1 ]
Hu, Yong-fang [1 ]
机构
[1] Peking Univ, Hosp 3, Therapeut Drug Monitoring & Clin Toxicol Ctr, Beijing 100191, Peoples R China
[2] Peking Univ, Sch Pharmaceut Sci, Dept Pharm Adm & Clin Pharm, Beijing 100191, Peoples R China
[3] Peking Univ, Hosp 3, Ctr Reprod Med, Beijing 100191, Peoples R China
关键词
IVF; FSHR; Single nucleotide polymorphism; Meta-analysis; GENE POLYMORPHISMS; HYPERSTIMULATION; IVF; PHARMACOGENETICS; INFERTILITY; GENOTYPE;
D O I
10.1016/j.ymgme.2011.04.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: A common follicle-stimulating hormone (FSH) receptor (or FSHR) polymorphism Ser680Asn (rs6166) was found to be associated with altered ovarian response in women undergoing in-vitro fertilization. To further investigate such an association, a meta-analysis was conducted. Methods: A PubMed literature search was conducted to identify all cohort studies investigating such a relationship. The following parameters-basal FSH levels, total FSH doses, oocytes retrieved, and pregnancy rates-were used to evaluate the ovarian function, its response to exogenous FSH and in-vitro fertilization and intracytoplasmic sperm injection outcome. Results: A total of 1421 cases were collected from eight studies. Of them, a significantly lower basal FSH level was observed in patients harboring Asn/Asn (NN) genotype than those carrying the Ser/Ser (SS) genotype both in Asian (WMD: -2.57 mIU/ml, 95% CI: -2.96 to -2.19, P<0.0001) and Caucasian retrospective groups (WMD: -1.86 mIU/ml, 95%CI: -2.07 to -1.66, P<0.0001) with no heterogeneity. Moreover, carriers of the SS tended to require greater FSH doses than NN (WMD: -268.82 IU, 95% CI: -561.28 to 23.63, P = 0.07). Other parameters, such as oocytes retrieved and pregnancy rate, were not significantly different between the groups. Conclusion: Carriers of the SS variant have slightly higher basal FSH levels, tending to require higher doses of exogenous FSH for stimulation. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:388 / 393
页数:6
相关论文
共 50 条
  • [21] Follicle-Stimulating Hormone Receptor (FSHR) Ser680Asn Genotype Does Not Affect the Follicular Fluid Hormonal Profile in Stimulated Cycles Using Different Gonadotropin Preparations for Ovulation Induction: A Pilot Study
    Papamentzelopoulou, Myrto-Sotiria
    Mavrogianni, Despoina
    Liokari, Emmanouela
    Stavros, Sofoklis
    Potiris, Anastasios
    Doumplis, Dimitris
    Loutradis, Dimitrios
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (06)
  • [22] Follicle-stimulating hormone or human menopausal gonadotropin for ovarian stimulation in in vitro fertilization cycles: a meta-analysis
    Agrawal, R
    Holmes, J
    Jacobs, HS
    FERTILITY AND STERILITY, 2000, 73 (02) : 338 - 343
  • [23] Effect of follicle-stimulating hormone receptor N680S polymorphism on the efficacy of follicle-stimulating hormone stimulation on donor ovarian response
    Lledo, Belen
    Guerrero, Jaime
    Turienzo, Azahara
    Ortiz, Jose A.
    Morales, Ruth
    Ten, Jorge
    Llacer, Joaquin
    Bernabeu, Rafael
    PHARMACOGENETICS AND GENOMICS, 2013, 23 (05): : 262 - 268
  • [24] Effect of follicle-stimulating hormone receptor N680S polymorphism in the efficacy of follicle stimulating hormone stimulation on donor ovarian response
    Turienzo, A.
    Lledo, B.
    Guerrero, J.
    Ortiz, J. A.
    Morales, R.
    Ten, J.
    Llacer, J.
    Bernabeu, R.
    HUMAN REPRODUCTION, 2013, 28 : 330 - 331
  • [25] Clomiphene citrate resistance in relation to follicle-stimulating hormone receptor Ser680Ser-polymorphism in polycystic ovary syndrome
    Overbeek, A.
    Kuijper, E. A. M.
    Hendriks, M. L.
    Blankenstein, M. A.
    Ketel, I. J. G.
    Twisk, J. W. R.
    Hompes, P. G. A.
    Homburg, R.
    Lambalk, C. B.
    HUMAN REPRODUCTION, 2009, 24 (08) : 2007 - 2013
  • [26] Combined study on the single nucleotide polymorphisms in the follicle-stimulating hormone receptor (Ser680Asn) and anti-Mullerian hormone receptor type II (-482A>G) as genetic markers in assisted reproduction
    Papanikolaou, Ioannis C.
    Giannelou, Polina
    Anagnostou, Elli
    Mavrogianni, Despoina
    Drakakis, Petros
    Loutradis, Dimitrios
    HORMONE MOLECULAR BIOLOGY AND CLINICAL INVESTIGATION, 2019, 38 (01)
  • [27] Association of Thr307Ala and Asn680Ser of Follicle-Stimulating Hormone Receptor Gene Polymorphisms with Gonadotropin Administration during Controlled Ovarian Hyperstimulation
    Meng, Qing-Xia
    Song, Dan
    Li, Hong
    Wang, Wei
    Ou, Jian
    Xu, Yong-Le
    Zheng, Ai-Yan
    REPRODUCTIVE AND DEVELOPMENTAL MEDICINE, 2018, 2 (02) : 81 - 87
  • [28] Association of Thr307Ala and Asn680Ser of Follicle-Stimulating Hormone Receptor Gene Polymorphisms with Gonadotropin Administration during Controlled Ovarian Hyperstimulation
    Qing-Xia Meng
    Dan Song
    Hong Li
    Wei Wang
    Jian Ou
    Yong-Le Xu
    Ai-Yan Zheng
    生殖与发育医学(英文), 2018, 2 (02) : 81 - 87
  • [29] Performance of basal follicle-stimulating hormone in the prediction of poor ovarian response and failure to become pregnant after in vitro fertilization: a meta-analysis
    Bancsi, LFJMM
    Broekmans, FJM
    Mol, BWJ
    Habbema, JDF
    Velde, ERT
    FERTILITY AND STERILITY, 2003, 79 (05) : 1091 - 1100
  • [30] Assessment of ovarian reserve by using the follicle-stimulating hormone isoform distribution pattern to predict the outcome of in vitro fertilization
    Letterie, Gerard S.
    Lee, James S.
    Padmanabhan, Vasantha
    FERTILITY AND STERILITY, 2006, 86 (05) : 1547 - 1549